TECH OFFERS

With a projected market size of close to US$300M in 2025, printed thin film batteries are emerging as ideal candidates to power the next-generation wearables, medical and electronic devices. Unlike conventional batteries, printed thin-film batteries offers form-factor freedom, flexibility, providing power at sub-milimeter thickness and potentially cost effective to manufacture. Typically, zinc-manganese has been the chemistry of choice for printed batteries thanks to its low cost, high safety and ease of processing. Printed battery is manufactured by depositing conductive ink as a thin-film of paste onto a flexible polymer substrate (e.g., PET or heat-resistant polyimide films) by screen printing technique. Developed by an SME, the proprietary printed battery technology consists of layers of zinc anode, manganese dioxide cathode, electrolyte, separator, current collectors and sealing materials. The final battery is about 0.7 mm thick. While the energy capacities and size/shape could be customised depending on the use cases, the printed battery is best suited for applications at a power consumption of less than 50 mW. The technology owner may provide an initial assessment of the feasibility in using printed battery as a power source. If feasible, the technology owner may support in further brainstorming to optimise the power requirement and battery capacity for potential use cases. With a full grasp of the technical requirements, co-development activities including prototyping, battery integration with the final product (where applicable) will follow. For selected final products, the technology owner may serve as the original equipment manufacturer or original design manufacturer for the technology seeker. The standard non-rechargeable printed battery developed by the technology owner has the following technical specifications: Nominal voltage: 1.5 V to 3.0 V Initial capacities: 15 mAh @ 1 mA to 60 mAh @ 1 mA Initial internal resistance: ~20 Ω to ~90 Ω Maximum peak current: 25 mA for 5 ms Shelf life: minimum 2 years The outer dimensions, thickness and shape of battery as well as terminal size and location can be tailored according to the use cases: Customisation (area): 2 to 100 cm2 Customisation (capacity): up to 400 mAh Bending radius: the printed battery can be attached to a curved surface with a minimum radius of 35 mm. The thin film paper battery may be designed and customised to supply power to the following products and applications: Wireless sensor labels for temperature monitoring or asset tracking Wireless skin patches for monitoring vital signs Cosmetics patches and masks for skin care Smart wound healing dressings Intelligent packaging lighting, display and tracking New products that benefit from the thin and flexible form factor US$296M in 2025 and CAGR 24.7% from 2020-2025 (MarketsandMarkets, 2020) Customisable, flexible printed batteries for multiple applications. Printed battery, Flexible battery, Flexible electronics Energy, Battery & SuperCapacitor

Traditional methods of culturing organoids are labor-intensive, time-consuming, and limited in their ability to produce large quantities of organoids with consistent quality and characteristics. This technology enables the production of homogenized organoids of consistent quality. It utilizes specialized conditions to facilitate mass production and automate the cultivation of organoids derived from various tissues and organs, including the liver, kidney, lung, and brain. The IP addresses a need in the marketplace by providing a more efficient and cost-effective method of producing organoids. This technology reduces the time and cost of producing organoids while improving the reproducibility and scalability of the process. This can accelerate drug discovery and development, improve the accuracy of toxicology testing, enable the development of personalized medicine, and eventually replace the need for animal testing in the long-term vision of drug development. The technology provider will be producing the desired organoids as the end product with a further aim to enable a platform service for toxicity and efficacy testing when fully commercialized. The identity of the organoids will be validated by expression of relevant biomarkers. The end users of this technology are likely to be pharmaceutical companies, biotech firms, academic research institutions, and clinical laboratories. Overall, the technology has the potential to transform the way organoids are produced and used in the biomedical field. The technology owner is actively seeking for R&D collaboration to allow integration into existing protocols and testing with institutions, biotech companies and Contract Research Organizations (CROs). A bioink composition for organoids generation and characterisation Method for creating consistent cell droplets, culturing them in suspension, and sorting them by desired characteristics Cost-effective, leading to a 10x reduction in price Cryopreservation of organoids can be implemented for long-term storage and to ensure stable delivery This solution is intended to be a platform technology to be deployed in the biomedical industry, specifically in drug discovery on molecular drugs or gene therapies, toxicology testing, disease modeling, and personalized medicine, as well as CROs providing testing services and biotech firms developing early-stage drugs. The products that can be marketed based on this technology are organoid assays derived from various human tissues and organs, such as liver, kidney, lung, and brain. These organoids can be used for various applications, including: Testing drug toxicity and efficacy Investigating disease mechanisms and identifying drug targets Developing personalized therapies for patients The organoids market is projected to grow at a significant rate in the coming years, with an increasing demand for personalized medicine and improved drug discovery and toxicology testing methods. According to a report by MarketsandMarkets, the organoids market is expected to reach USD 1,642 million by 2025, growing at a CAGR of 20.4% from 2020 to 2025. The drug discovery outsourcing market was valued at USD 4.03 billion in 2020 and is also expected to grow at a compound annual growth rate (CAGR) of 7.8% from 2021 to 2028, according to a report by Grand View Research. The increasing demand for novel and effective drugs, the rising cost of in-house drug development, and the need to expedite drug development timelines are some of the key factors driving the growth of this market. Pharmaceutical and biotech companies, as well as academic research institutions, are among the key buyers of drug discovery outsourcing services. These companies outsource drug discovery services to Contract Research Organizations (CROs) and Contract Development and Manufacturing Organizations (CDMOs) to reduce costs and accelerate drug development timelines. The technology represents a significant improvement over the current state-of-the-art in organoid production. Currently, the most common methods for organoid production involve manual culturing, which is prone to variability and can be time-consuming and labor-intensive. Although some automation, such as the use of microfluidics and robotics, has been incorporated into organoid production, these methods are still limited in terms of organoid yield and quality. Our technology offers several advantages and differentiates itself from competitors in several ways: Scalability: One of the key advantages of this technology is its ability to scale up organoid production to an industrial level. The homogenization and suspension of organoids allow for efficient automation and mass production of organoids, reducing the time and cost of production. Standardization: The technology offers a more standardized and reproducible process for organoid production, reducing variability between batches and improving the accuracy of drug testing and development. Versatility: The technology can be applied to generate organoids from various organs and tissues, allowing researchers to study multiple disease models in a more comprehensive manner. This versatility allows for a wider range of applications and increases the potential market size. Cost-effectiveness: The streamlined process and scalability of the technology can lead to significant cost savings compared to other organoid production methods, making it more accessible to researchers and companies. Homogenized organoids, mass production, automation, drug discovery, toxicology testing, personalized medicine, reproducibility, scalability, transformative technology Healthcare, Pharmaceuticals & Therapeutics, Manufacturing, Additive Manufacturing, Life Sciences, Industrial Biotech Methods & Processes

Three-dimensional (3D) coil winding technology is a significant development in the field of coil manufacturing, enabling the creation of smaller, more efficient, and more complex coil structures. The need for 3D coil winding arises from the increasing demand for compact, high-performance electronic devices in various applications such as medical devices, automotive, aerospace, and communication equipment. These devices require coils that can fit into tighter spaces and operate at higher frequencies. Additionally, there is a growing need for coils with more complex shapes and designs to improve their performance and reduce manufacturing costs. This technology offer is a 3D coil winding method to produce complex coil structures. The method allows for precise control of the winding process, which enables the creation of coils with a wide range of shapes, sizes, and configurations. The technology can also incorporate multiple wires, producing multi-layered and multi-phase coils within the same structure. The technology owner is keen to do R&D collaboration and license the 3D coil winding technology to application developers from various industries.  This technology offer consists of a coil winding method that has the following features: Stable magnetic field distribution: The coil winding produced by this technology provides a stable magnetic field distribution, ensuring optimal performance of the electronic device. Space-saving: This technology allows for the production of smaller and more compact coils, which is critical in modern electronic devices where space is at a premium. Customization: 3D winding technology allows for the production of coils with a wide range of shapes, sizes, and configurations, making them ideal for various applications. Greater Flexibility: The ability to produce complex coil structures with 3D winding technology opens up new possibilities for the design of electronic devices, leading to new innovations and advances in technology. This technology offer can be customised for various applications, such as: Medical Devices: 3D coil winding technology can be used to manufacture coils for medical devices such as MRI machines and pacemakers, where performance and compact design are critical. Automotive: Coils produced using 3D winding technology can be used in various automotive applications such as sensors, actuators, and motors. Aerospace: 3D coil winding technology can be used in aerospace applications such as satellite systems, radar, and avionics. Communication Equipment: The technology can be used to manufacture coils for communication equipment such as antennas, receivers, and transmitters. Industrial Automation: Coils produced using 3D winding technology can be used in industrial automation applications such as robotics, servo motors, and machine tools. Power delivery: 3D coil winding technology can be used in high-power delivery, such as wireless charging for higher power density, improved thermal management, efficient and reliable designs. The unique value proposition of 3D coil winding technology is its ability to produce compact and efficient coils with complex shapes, sizes, and configurations, leading to improved performance, space-saving, and cost-effectiveness. This technology offer is a more advanced and precise method of coil winding, resulting in stable magnetic field distribution, thinner overall coil structure, and the ability to combine multiple structures into the same plane. These features make it an attractive option for a wide range of applications, including medical devices, automotive, aerospace, communication equipment, industrial automation, and renewable energy systems. The technology owner is keen to do R&D collaboration and licensing the 3D coil winding technology to application developers from various industries.  Electronics, Interconnects

Diabetes is a prevalent and growing health problem worldwide, affecting 1 in 10 people, with 90% of cases being type 2 diabetes. Congenital diabetes also affects 1 in 6 live births. In the next 20 years, diabetes is projected to increase by 46%. More than half a billion people are affected globally, 400,000 of them are in Singapore and if nothing is done by 2050, there will be one million diabetics patients in Singapore.   The company offers two technical solutions in form of a blended powder format: 1) Low Glycaemic Index (GI) and 2) Low Glycaemic Index (GI) with added protein.   The blend is plant-based, a source of protein, high in dietary fibre and replaces sugar from 20% to 100% in recipes across various food and beverage applications, it is versatile, high solubility, no alternation to original taste.   The solution is primarily targeted at Food Service sectors operators and manufacturers who seeks to penetrate the reduced sugar food & beverage market.  The technology consists of a proprietary blend (formulated by a renowned research institute based in Singapore) and consist of ingredients and composition that has clinically proven results of lowered GI. Affordable and cost effective compared to functional sugars No alteration to original taste of recipe Versatility of application due to its high solubility The applications include but are not limited to: Beverage Products (Bubble Tea, Ready-To-Drink, Pre-Packaged, Hot & Cold Beverages) Bakery Products (Cookies, Muffins, Pies, Tarts, Cakes, Brownies) Dairy (Milkshakes, Ice Creams, Gelato, Frozen Yogurt) Desserts (Asian & Western) The global reduced sugar food & beverage market size is at US$46.1bil, growing at CAGR of 9.53% in next 5 years, APAC is the fastest growing region, valued at US$12.9bil. It is a global movement to fight against diabetes through educational campaigns and government intervention. The Singapore Government decided to introduce mandatory nutrition labels and advertising prohibitions for Nutri-Grade beverages across all formats. The innovative solution offers immense versatility, catering to a broad spectrum of food items. Unlike the current state-of-the-art, which primarily focuses on baked goods and rice, the technology is not restricted to the same spectrum offered by competitors. The potential applications of the technology are limitless, offering a significant advantage over existing solutions. Furthermore, clinical trials have been conducted to validate the efficacy of the technology in food product sets them apart from the current state-of-the-art. In addition, the company possess the technological capabilities to demonstrate the effectiveness and efficacy of their solution across a broad range of food items. This ability to provide concrete evidence of their technology's efficacy offers a compelling advantage to customers looking to adopt innovative, effective, and reliable solutions to meet the demands of the growing diabetic and obese market. Low GI, Low Glycaemic Index, Low Glycaemic Load, Diabetics friendly, Low Glycemic Index, Obesity, Reduced sugar, Better for you, Keto friendly, Plant based, vegan, Healthier choice, HCS, Nutri grade, Halal certified Foods, Ingredients

Terahertz (THz) radiation is a form of electromagnetic radiation that lies in the frequency spectrum ranging between microwaves and infrared light. In the field of Non-Destructive Testing (NDT), THz radiation is utilised to inspect materials for imperfections or anomalies. THz radiation can penetrate numerous non-metallic materials and can reveal internal structures that are not visible in natural light or x-ray imaging. THz-based NDT finds applications in a variety of applicatins, including aerospace, electronics, and medical imaging. Each material possesses a unique fingerprint that enables its identification, differentiation, condition, quantification, and quality of materials through spectroscopy. This technology offer is a spectral sensing technique that utilises accessible terahertz technology. It includes a portable device equipped with industrial-grade sensors and cloud-based data analytics. The technology owner is keen to engage in R&D collaboration with industrial partners in various industries, including pharmaceuticals, food packaging quality inspection and public safety inspection.     The technology offer is a reliable solution for non-disruptive inspection and measurement of materials:  It boasts high accuracy and multi-layer penetration capabilities. The accuracy rate of 95% in laboratory conditions provides users with confidence in the results produced. The wide measurement range of 30μm to 100μm and beyond with an accuracy of approximately ±4μm makes it suitable for various applications. The multi-layer penetration capability of up to four layers of material allows for the inspection of layered materials or detection of defects within multiple layers. Designed to increase productivity and efficiency, the technology provides accurate measurements and multi-layer penetration capabilities for faster decision-making and efficient use of resources. The technology offer is versatile, suitable for quality control and inspection in the manufacturing, electronics, medical, and aerospace industries.   This technology offer can be expanded and deployed in various industry such as: Package inspection Security and screening Spectroscopy, medical imaging Material science, chemical analysis Food quality control Terahertz (THz) technology offers numerous advantages over other radiation-based technologies. One key benefit is its ability to penetrate non-conductive materials, making it useful for imaging and inspecting plastic, paper, wood, cloth, ceramics, and other materials. THz technology is also safe and non-radioactive, making it a preferred choice for imaging and analysis. THz technology is non-contact and non-destructive, making it an ideal tool for Non-Destructive Testing (NDT) applications. It can detect defects and flaws within materials without requiring physical contact and provides high-resolution images with sub-millimeter accuracy. THz technology is valuable for composition identification by analyzing the spectral fingerprints of materials, allowing for non-invasive identification and characterization of materials. This feature is useful for security, pharmaceuticals, and food analysis applications. The technology owner is keen to engage in R&D collaboration with industrial partners in various industries, including pharmaceuticals, food packaging quality inspection and public safety inspection. mmwave, terahertz Electronics, Sensors & Instrumentation, Radio Frequency

The traditional coiling method involves the use of flat, planar coils that are wound in a circular or rectangular shape around a core material.  These flat coils generate a magnetic field that is used to transfer energy wirelessly from a charging pad to a device that is compatible with wireless charging technology. This technology offer is a three-dimensional (3D) coil winding method that can provide improved and stable magnetic field that results in increased efficiency and flexibility. This technology allows products to be adapted to suit various forms, shapes and sizes, making it a highly versatile option for a range of applications.  The technology owner is keen to do R&D collaboration with application developers from various industries where wireless power transfer is required. Their goal is to further improve this technology and apply it to a wider range of products and use cases. The main features and benefits offered by the wireless power transmission technology are: Flexible design that can conform to irregular shapes and sizes Space saving design by integrating multiple coils into a product Weight reduction up to 50%; Physical size reduction up to 50% Comply with IP67 for outdoor usage; resistant to dust and water Ideal for portable devices, electric vehicles, home appliances and harsh environment This wireless power transmission technology can be deployed in a wide range of applications where wireless power transfer is needed, such as, the following applications and examples: Wearables: Typically, smartwatches and fitness trackers are small and have irregular shapes, making it difficult to charge them using traditional flat coils. 3D shaped coils can accommodate the irregular shapes of these devices and improve the efficiency of wireless charging. Electric Vehicles: Wireless charging technology is used to improve the electric vehicles usability and convenience. 3D shaped coils could be used to create charging pads that can fit into the irregular shapes of electric vehicle batteries, making charging more efficient and reliable. Medical Devices: Pacemakers and some hearing aids are often implanted in the body, making it difficult to charge them using traditional charging methods. 3D shaped coil winding could be used to create charging systems that can wirelessly charge these devices without the need for invasive procedures. Home Appliances: Home appliances such as smart speakers, lamps, and toothbrushes can be integrated with 3D shaped coil to create charging pads, improving their usability and convenience. Delivery robots: Sidewalk robots, drones and other delivery robots are increasingly adopting self-charging systems to improve operational efficiency. 3D shaped coils can accommodate the irregular shapes of these robots, and making charging more safely outdoors. The unique value proposition of wieless power transmission with 3D coil winding technology lies in its ability to address some of the pain points associated with traditional flat coil winding methods, such as: Enhanced flexibility that can accommodate irregular shapes and sizes Cost savings by reducing material wastage associated with traditional flat coil winding methods Improved durability and robustness; less prone to breakage The technology owner is keen to do R&D collaboration with application developers from various industries where wireless power transfer is required.   Electronics, Power Management, Interconnects

Plywood is a preferred material used in furniture and home building for its durability since the Egyptian and Roman times. In 2019, the world consumed 165 million cm3 of plywood and was responsible for the creation of more than 3 billion tons of CO2. Applications for plywood are widespread including construction, home, retail, and office interior works and furnishings such as cabinetry, woodworking, renovations, and outfitting. Regulations and protectionism to slow down deforestation plus the tightening of sustainable forestry management lessen the supply of logging for plywood.  As global demand continues to be strong, the search for a viable replacement for plywood has become more pressing. More importantly, it is important to find a non-wood-based replacement with similar performance to plywood. Plywood is desirable because of its superior performance properties. Alternatives like medium-density boards (mdf) and particle boards are made from recycled wood waste. Unfortunately, plywood can only be made from virgin wood and there are no direct replacements for plywood currently. This technology leverages the global abundance of lignocellulosic fibre waste which is the discarded waste material after the harvesting and production of palm oil, rice, and wheat. The technology transforms these lignocellulosic fibre wastes into a direct replacement for conventional plywood.  This provides a sustainable, economically viable, and environmentally friendly solution to the continuing demand for plywood and the resolution to the growing lignocellulosic fiber waste problem in agri-food-based countries all over the world. The technology owner is open to various forms of collaboration including IP licensing, R&D collaboration, and test-bedding with different types of agrifood sidestreams. In the case of palm biomass waste, rice, and wheat straw waste, the technology is ready for commercialization. Produced material comparable to Grade A plywood in all performance parameters including modulus of rupture (MOR), modulus of elasticity (MOE), and water swelling Lower CAPEX & OPEX compared to producing conventional plywood Conversion process able to utilize standard commercial manufacturing equipment Activates the lignin within the agricultural biomass and transforms it into a 'natural superglue’ without commonly used formaldehyde-based binders Utilizes a series of hot presses under swinging and cyclical pressures and temperatures Construction Furniture Packaging Sports Equipment Automotive Industry Marine Industry Based on market research, the plywood industry is projected to experience significant growth from $54.79 billion in the current year to $85.26 billion by 2027, at a compound annual growth rate (CAGR) of 9.4%. With the increasing demand for sustainable materials and the valorization of agricultural waste, there is a potential opportunity for technology to emerge as a sustainable substitute for plywood in this expanding market. Sustainable solution as a direct replacement to plywood that reduces deforestation and recovers tremendous amounts of CO2 Non-added formaldehyde (NAF) Valorized plywood replacement comparable to Grade A plywood A credible global solution that contributes to reversing climate change Valorisation, agrifood, waste to worth, high value Waste Management & Recycling, Food & Agriculture Waste Management, Sustainability, Circular Economy

Capsule endoscopy is a non-invasive diagnostic method that utilizes a tiny, wireless camera capsule to capture images of the digestive system, which aids in identifying various conditions. Studies indicate that colon cancer is the leading cause of cancer-related deaths among men aged 20-49, and capsule endoscopy is the least invasive examination capable of detecting the early stages of this cancer, alongside other pathologies such as inflammatory bowel disease, ulcers, tumors, and gastro-intestinal bleeding. Without this procedure, these conditions often go undetected and become untreatable by the time noticeable symptoms appear. This technology offer is a remote capsule endoscopy examination, aiming to make colon diagnosis more widespread among people and extend its use to animals, primarily pets like dogs. Regular capsule endoscopy colon screenings are the only way to prevent the growth of undetectable pathologies. Remote technology enables patients to move around or work without needing to stay in a medical facility, allowing diagnoses to be conducted in areas previously unreachable by capsule endoscopy, such as on battlefields, in underdeveloped regions, or even by astronauts in space. The system includes an artificial intelligence module that automatically identifies and suggests potential pathologies in the images to the examining physician. This information assists doctors in quickly navigating through the collection of images, and it can help detect pathologies that may necessitate a more invasive diagnosis or immediate treatment. The technology owner is eager to engage in R&D collaboration with product development partners for gastro-intestinal endoscopic applications for both humans and animals. The AI-supported remote endoscopic capsule system is an innovative medical technology boasting several key features, such as: Remote diagnosis and examination: This system enables capsule endoscopy diagnosis and examination to occur at any location with a stable internet connection, eliminating the need for a specialized medical facility. Expanded examination scope: The examination monitors not only the small intestine but also the large intestine and stomach. Affordability: Examination costs for patients are several times lower than traditional capsule endoscopy, as the system uses significantly more affordable microcontrollers instead of costly, dedicated electronic components. Automatic pathology recognition: The system employs artificial intelligence algorithms to automatically detect pathologies, assisting doctors in diagnosing and reducing examination analysis time by an average of 3-4 times. High image resolution: The capsule utilizes cutting-edge optical technologies, enabling it to capture images with 50% higher resolution compared to competitors. Cloud storage connectivity: The system comes equipped with cloud storage connectivity, allowing easy access to patient data and images from anywhere globally. 94% effectiveness: This indicates that the system is highly successful in identifying and diagnosing medical conditions. 97.4% sensitivity: This high sensitivity rate means that the system is highly accurate in detecting potential health issues. This technology can be applied across various MedTech industry applications, such as: Gastroenterology: Useful for diagnosing and monitoring digestive tract conditions. Oncology: Valuable for detecting and monitoring cancers within the digestive tract. Sports Medicine: Applicable for diagnosing and monitoring injuries, including concussions, in sports medicine. Veterinary Medicine: Beneficial for diagnosing and monitoring digestive tract conditions in animals. This technology can also be further refined for use in the following applications: Industrial Inspection: Applicable in industries like oil and gas, aerospace, and manufacturing for remote visual inspections of internal structures and components, including pipelines, engines, and turbines. Military and Defense: Suitable for military and defence applications, such as inspecting hard-to-reach areas in aircraft or other vehicles. The technology offer boasts the following distinctive features: Remote control access: Accessible from any location worldwide with an internet connection. Affordability: Holds the potential to become a regular diagnostic tool. Minimally invasive: Eliminates the need for sedation or physically inserting a camera into the body, offering a less invasive alternative to traditional endoscopy procedures. Comfort: The procedure is painless and comfortable, with no requirement for anesthesia or sedation. Diagnostic accuracy: Delivers detailed images of the gastrointestinal tract that may not be visible using traditional endoscopy procedures, making it valuable for diagnosing conditions like inflammatory bowel disease, ulcers, and tumors. Convenience: Capsule endoscopy can be conducted in an outpatient setting, allowing patients to resume their normal activities immediately following the procedure. The technology owner is eager to engage in R&D collaboration with product development partners for gastro-intestinal endoscopic applications for both humans and animals. endoscopic, capsule-camera, diagnostics, non-invasive, remote, affordable Electronics, Sensors & Instrumentation, Healthcare, Diagnostics, Medical Devices

Smart Inhalers pose great potential in empowering disease management. Common difficulties faced by patients in the use of inhalers include inaccurate dosing, incorrect inhalation technique, insufficient deep inspiration flow rate and compliance. This technology aims to tackle the issue of over or underdosage delivery, device misuse and lack of monitoring or analytics found in current technologies. Using its proprietary precision dosing system, the device can accurately control dosages with an error rate of as low as 4% while enabling intelligent therapy monitoring and medical reporting for improved patient adherence and treatments. The device functions by breath-activated operation to prevent wastage, heat-free fine particle liquid nebulization for safer drug delivery and deeper lung deposition. It features a propellant-free compact (pocket-sized) smart inhaler with liquid drug cartridges designed to replace injections and modernize inhaled therapies using the lung as a platform for delivery, addressing the lack of pain-free, hassle-free, smart alternatives for various medications. Due to its proprietary atomizer that works on almost 90% of most liquid medication, it has significant potential to be scaled in various drug types and markets, such as insulin, antivirals, hormones, and smart intranasal delivery for neurological conditions.  The technology owner is actively seeking collaboration opportunities with commercialization partners, pharmaceutical, biotech, OEM, CRO companies, who can license it to bring it to market or integrate it into existing healthcare systems. This scalability makes the technology highly appealing to a wide range of potential partners and licensees including co-development for customization and R&D or joint venture.   Proprietary precision dosing system: Built-in circuitry that continuously monitors and controls consistent piezo's operation. Ensures accurate, stable, and quantifiable volume of liquids being atomized. Deep penetration and targeting: Patented technology engineers the piezo to stably operate around the optimal 2.5 microns for deep deposition into lungs. (Particles around 1 micron are exhaled because they are too light/small, particles above 4 microns are stuck in throat as they are too big/heavy). Programmable: Precision dosing can be controlled via device and phone by engineering a cut-off function so that device will not atomize when inhaled. Customization: Different formulations and multi-drug mixture in one pod or double cartridge delivery system. Flexibility: Options to deliver a wider range of medications, including micro-dosing (as low as 0.03ml/5secs) for more targeted and personalized treatment. Reducing the risk of adverse side effects and allowing for more effective treatment for sensitive patients. Heat-free and propellant-free nebulization: Does not affect medication degradation. Works with liquid medication (depends on viscosity of fluid). Breath-activated suction cap: Device does not have buttons. Intelligent therapy monitoring: The device automatically time stamps and captures each dose helping healthcare professionals track the progress of the therapy remotely. Liquid disposable cartridge system: Quick and hygienic medication replacement without the need for manual cleaning or maintenance of the inhaler. This reduces the risk of contamination or dosing errors. Patient-designed convenience: Non-removable rechargeable battery lasting up to one week before recharging. User friendly for patients to take their medication anytime and anywhere. Industries where this technology can be deployed include: Pharmaceutical and biotechnology companies Medical device manufacturers Healthcare providers and clinics Digital health platforms and telemedicine services Diabetes care Value added generic medicine Potential products based on this technology include: Broadening the arsenal of therapeutic options for the Health Care Providers New alternative to injections and current inhalation devices Smart intranasal delivery devices for neurological conditions and mental health treatments, increasing the potential for targeted drug delivery to the brain Integration with other health monitoring apps for better adherence and reporting (like continuous glucose monitors) Developing inhalable versions of pain-relief medications for patients who struggle with swallowing pills or require rapid onset of pain relief Smart inhalers for insulin delivery Faster and more efficient way to deliver antibiotics for respiratory infections, such as pneumonia or bronchitis, potentially reducing treatment duration and improving patient outcomes A more comfortable and less invasive method for administering vaccines, potentially increasing vaccination rates and improving public health Developing targeted inhalable chemotherapy or immunotherapy treatments for lung cancer or other respiratory-related malignancies, potentially reducing systemic side effects and increasing treatment efficacy The approximate market size for this smart inhaler technology can be substantial, given its potential applicability across various therapeutic areas. The global inhaler market was valued at around US$39.3 Billion in 2022 while the diabetes management market US$92.97 Billion. Considering the smart inhaler's ability to address both the pulmonary drug delivery and daily injection markets, the Total Available Market can be up to a US$1 Trillion adding up all the therapeutic areas. This proprietary smart inhaler technology represents a significant improvement over the current "State-of-the-Art" in drug delivery systems. Its unique value lies in its combination of precision dosing, versatility, and improved patient experience. Benefits for healthcare professionals and patients include: Ensuring accurate dose administration, driving therapy effectiveness Greater therapy monitoring and personalized care Differentiating drug offerings and broadening therapeutic options for healthcare providers Simplifying drug delivery, increasing patient satisfaction Intelligent therapy monitoring and medical reporting features leads to enhanced patient experience Health-economic benefits: Reducing waste and optimizing resource utilization Enhancing adherence, leading to better health outcomes and reduced healthcare costs Expanding the reach of insulin therapy to more people, addressing unmet needs Potential cost savings for payers Pricing flexibility that accounts for the benefits of the new application Benefits for partners: By maximizing drug portfolio potential, this technology allows pharmaceutical companies to diversify, differentiate, and defend against patent expiration, leading to improved patient outcomes and market growth Inhaled Drug Delivery, Medical Device, Remote Diagnostics, Patient-centric healthcare, Personalized medicine, Nebulization, Patent-protected technology, Alternative to injections, Chronic disease management, Digital health innovation Electronics, Sensors & Instrumentation, Healthcare, Medical Devices, Telehealth, Medical Software & Imaging, Pharmaceuticals & Therapeutics, Life Sciences, Industrial Biotech Methods & Processes